Radiotherapy (RT) is delivered for purposes of local control, but can also exert systemic
effect on remote and non-irradiated tumor deposits, which is called abscopal effect. The view …

Hepatocellular carcinoma (HCC) is a prevalent disease with a progression that is modulated
by the immune system. Systemic therapy is used in the advanced stage and until 2017 …

There are currently more than 1000 prescription medications available for use in the United
States and more than 100,000 over-the-counter herbal and dietary supplements (HDS) …

Since the first Immune Checkpoint Inhibitor was developed, tumor immunotherapy has
entered a new era, and the response rate and survival rate of many cancers have also been …

Abstract Background & Aims Checkpoint inhibitors (CPI) account for increasing numbers of
drug-induced liver injury (DILI) cases. We aimed to determine the incidence rate and risk …

Numerous research reports have witnessed dramatic advancements in cancer therapeutic
approaches through immunotherapy. Blocking immunological checkpoint pathways …

Acute liver failure (ALF) is a rare, acute, potentially reversible condition resulting in severe
liver impairment and rapid clinical deterioration in patients without preexisting liver disease …

Drug-induced liver injury (DILI) remains an important, yet challenging diagnosis for
physicians. Each year, additional drugs are implicated in DILI and this year was no different …

Idiosyncratic drug-induced liver injury (DILI) is common in gastroenterology and hepatology
practices, and it can have multiple presentations, ranging from asymptomatic elevations in …

In recent years, cancer immunotherapy has made remarkable achievements. Immune
checkpoint inhibitors (ICIs) have been used successfully in several types of cancer in the …